报价延迟最少15分钟:2026/01/02 03:29 EST
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
26.59 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
0.75/0.61
|
|
企业价值
431.55M
|
| 资产负债 |
|
每股账面净值
8.71
|
| 现金流量 |
|
现金流量率
0.01
|
| 损益表 |
|
收益
10.22M
|
|
每股收益
0.36
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others. |
